---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-004428"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T04:37:15.763952+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Lyra Therapeutics posts corporate presentation; no new facts extractable from exhibit content provided

## Summary
- Company furnished a corporate presentation as Exhibit 99.1 to the SEC on January 10, 2025.
- The full content of the presentation is not included in the filing text submitted for analysis.
- Investors should view the presentation on Lyra's website for any updates on strategy or pipeline.
- No specific financial or operational numbers, guidance changes, or milestones are disclosed in the 8-K body.

## SEC filing metadata
- accession: 0001193125-25-004428
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312525004428/0001193125-25-004428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312525004428/d905375d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-004428
- JSON: https://secwatch.observer/filing/0001193125-25-004428.json
- Plain text: https://secwatch.observer/filing/0001193125-25-004428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.